CAS: 155488-25-8 - Urea,N-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]-
Fórmula:C28H30N6O3
- Sinónimos:
- Urea,N-[1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]-,(R)-
- Sograzepide
- Yf 476
- 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea
- (R)-1-[2,3-Dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea
- (R)-1-(1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-(3-(methylamino)phenyl)urea
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea
Producto controladoCAS:155488-25-8
N-[(3R)-1-(3,3-Dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]urea (GZ4081) is a drug that inhibits gastrin secretion by blocking the G protein coupled …
Fórmula:
C28H30N6O3
Pureza:
Min. 95%
Peso molecular:
498.58 g/mol
Ref: 3D-FD153499
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Sograzepide-d3
Producto controladoCAS:155488-25-8
Fórmula:
C28D3H27N6O3
Forma y color:
Neat
Peso molecular:
501.595
Ref: TR-S675802
100mg | 20.168,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Sograzepide
Producto controladoCAS:155488-25-8
Fórmula:
C28H30N6O3
Forma y color:
Neat
Peso molecular:
498.576
Ref: TR-S675800
100mg | 20.168,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Sograzepide
CAS:155488-25-8
Sograzepide (Netazepide) is a gastrin/CCK-B antagonist, inhibits gastrin/CCK-A activity, and can induce regression of type …
Fórmula:
C28H30N6O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
498.58
Ref: TM-T16906
1mg | 91,00 € | ||
5mg | 327,00 € |
Entrega estimada en Estados Unidos, el Lunes 13 de Enero de 2025